We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 6,592 results
  1. Effectiveness of immunoglobulin replacement therapy in preventing infections in patients with chronic obstructive pulmonary disease: a systematic review

    Purpose

    Immunoglobulin replacement therapy is a standard treatment for patients with antibody production deficiencies, which is of interest in...

    Justin J. Y. Kim, Liz Dennett, ... Adil Adatia in Allergy, Asthma & Clinical Immunology
    Article Open access 10 April 2024
  2. Controversies about immunoglobulin replacement therapy in HSCT recipients with hypogammaglobulinemia

    The efficacy of immunoglobulin replacement therapy (IgRT) has been demonstrated for primary immune deficiency diseases and hematological malignancies...

    Akihiro Ohmoto, Shigeo Fuji, ... Hermann Einsele in Bone Marrow Transplantation
    Article 19 April 2022
  3. A clinician’s guide for administration of high-concentration and facilitated subcutaneous immunoglobulin replacement therapy in patients with primary immunodeficiency diseases

    Immunoglobulin replacement therapy is the standard-of-care treatment for patients with primary immunodeficiency diseases who have impaired antibody...

    Kristin Epland, Daniel Suez, Kenneth Paris in Allergy, Asthma & Clinical Immunology
    Article Open access 30 September 2022
  4. Immunoglobulin replacement therapy in patients with immunodeficiencies: impact of infusion method on patient-reported outcomes

    Background

    Understanding the impact of different immunoglobulin (Ig) infusion methods (intravenous [IVIg] and subcutaneous [SCIg]) upon treatment...

    Rajiv Mallick, Geneviève Solomon, ... Oleksandra Lepeshkina in Allergy, Asthma & Clinical Immunology
    Article Open access 24 December 2022
  5. Advances in Immune Tolerance Induction in Enzyme Replacement Therapy

    Inborn errors of metabolism (IEMs) are a group of genetic diseases that occur due to the either deficiency of an enzyme involved in a...

    Aslı İnci, Fatih Süheyl Ezgü, Leyla Tümer in Pediatric Drugs
    Article Open access 25 April 2024
  6. Autonomic neuropathy improving after intravenous immunoglobulin therapy

    Claudia Alberti, Jacopo Spagliardi, ... Eduardo Nobile-Orazio. in Clinical Autonomic Research
    Article 01 April 2024
  7. A comparison of the clinical efficacy of tonsillectomy with steroid pulse therapy and tonsillectomy therapy alone for patients with immunoglobulin A nephropathy: a retrospective observational study

    Background

    Tonsillectomy with steroid pulse therapy (TSP) and tonsillectomy monotherapy (T) have improved the prognosis of patients with...

    Ryosuke Sato, Risa Wakisaka, ... Miki Takahara in Clinical and Experimental Nephrology
    Article 18 June 2024
  8. Case report: enzyme replacement therapy for Fabry disease presenting with proteinuria and ventricular septal thickening

    Fabry disease (FD) is an uncommon, X-linked, lysosomal storage disease that causes defects in the glycosphingolipid metabolic pathway due to...

    Zewei Chen, Bo Yin, ... Tianyang Ye in BMC Nephrology
    Article Open access 21 February 2024
  9. Testosterone improved erectile function by upregulating transcriptional expression of growth factors in late androgen replacement therapy model rats

    We previously showed that castration of rats reduced erectile function over time; when testosterone replacement therapy was started 4 weeks after...

    Tomoya Kataoka, Hiroto Ito, ... Kazunori Kimura in International Journal of Impotence Research
    Article 30 October 2022
  10. Hemolytic anemia associated with intravenous immunoglobulin in Kawasaki disease

    Background

    The administration of high-dose intravenous immunoglobulin (IVIG) is a standard treatment for the management of Kawasaki disease (KD). IVIG...

    Eun Jung Cheon, Jun Suk Oh in BMC Pediatrics
    Article Open access 20 January 2024
  11. Concurrent fabry disease and immunoglobulin a nephropathy: a case report

    Background

    Fabry disease (FD) is an X-linked, hereditary dysfunction of glycosphingolipid storage caused by mutations in the GLA gene encoding...

    Li-Na Zhou, Shao-Shao Dong, ... Wen Huang in BMC Nephrology
    Article Open access 01 November 2023
  12. Effect of intravenous immunoglobulin on the outcome of children with septic shock in a PICU: a retrospective cohort study

    The therapeutic efficacy of intravenous immuneglobulin (IVIG) on children with septic shock remains uncertain. Therefore, we endeavored to...

    Haixin Huang, Jian Chen, ... Yue-qiang Fu in European Journal of Pediatrics
    Article 21 September 2023
  13. Medication patterns and dosing guidance in pediatric patients supported with intermittent hemodialysis or continuous kidney replacement therapy

    Background

    Hemodialysis is a life-saving technology used during periods of acute or chronic kidney failure to remove toxins, and maintain fluid,...

    Autumn M. McKnite, Danielle J. Green, ... Kevin M. Watt in Pediatric Nephrology
    Article 05 December 2023
  14. Longitudinal profiling of anti-factor VIII antibodies in Japanese patients with congenital hemophilia A during factor VIII replacement and immune-tolerance induction therapy

    When patients with hemophilia A develop factor VIII (FVIII) inhibitors, FVIII replacement therapy becomes ineffective. Although immune-tolerance...

    Takuji Yoshimura, Shoko Furukawa, ... Keiji Nogami in International Journal of Hematology
    Article 03 May 2022
  15. Guillain–Barre syndrome: small-volume plasmapheresis versus intravenous immunoglobulin—3rd level hospital experience

    Background

    Specific treatment for Guillain–Barre syndrome is based on plasma exchange and intravenous immunoglobulin (IvIg). In develo** countries...

    Khaoula Balili, Nissrine Louhab, ... Najib Kissani in The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
    Article Open access 19 March 2024
  16. Use of corticosteroids in Norwegian patients with immunoglobulin a nephropathy progressing to end-stage kidney disease: a retrospective cohort study

    Background

    Despite several clinical trials, the use of corticosteroid therapy for treating immunoglobulin A nephropathy (IgAN) remains controversial....

    Mariell Rivedal, Yngvar Lunde Haaskjold, ... Thomas Knoop in BMC Nephrology
    Article Open access 29 January 2024
  17. Open surgical treatment for aortic arch and coronary artery aneurysms associated with immunoglobulin G4-related disease: a case report

    Background

    Immunoglobulin G4-related disease (IgG4RD) is a systemic autoimmune disease characterized by a dense lymphoplasmacytic infiltrate...

    Toshiki Yokoyama, Ryo Suzuki, ... Kimikazu Hamano in General Thoracic and Cardiovascular Surgery Cases
    Article Open access 14 August 2023
  18. Efficacy of Plasmapheresis and Immunoglobulin Replacement Therapy (IVIG) on Patients with COVID-19

    Since the rapidly evolving outbreak of COVID-19, several empirical therapeutic options have been recommended including the use of antivirals,...

    Ramtin Pourahmad, Bobak Moazzami, Nima Rezaei in SN Comprehensive Clinical Medicine
    Article 31 July 2020
Did you find what you were looking for? Share feedback.